- Cat. No.
- A10246
CUDC-101
CUDC-101 is a novel compound which inhibits multiple targets, which is designed to inhibit HDAC, EGFR and Her2.
Search by product name, CAS, target or catalog number. Press Down Arrow to reach product suggestions, Tab to move between links, and Escape to close suggestions.
CUDC-101 is a novel compound which inhibits multiple targets, which is designed to inhibit HDAC, EGFR and Her2.
Synonyms: Histone Deacetylase Inhibitor III,MS344
M344 is a potent inhibitor of HDAC with IC50 of 100 nM and able to induce cell differentiation.
Synonyms: ACY1215
ACY-1215 selectively targets and binds to HDAC6, thereby disrupting the Hsp90 protein chaperone system through hyperacetylation of Hsp90 and preventing the subsequent aggresomal protein degradation.
BRD9757 is a highly potent and selective HDAC6 inhibitor with an IC50 of 30 nM toward HDAC6.
Synonyms: Nexturastat-A,NexturastatA
Nexturastat A is an aryl urea derivative that acts as a potent and highly selective inhibitor of histone deacetylase 6 (HDAC6) (IC50= 5.02 +/- 0.60 nM).
LMK-235 is a selective histone deacetylase (HDAC) 4 and HDAC5 inhibitor.
Tubastatin A is a potent and selective HDAC6 inhibitor with IC50 of 15 nM in a cell-free assay, and is selective (1000-fold more) against all other isozymes except HDAC8 (57-fold more).
Givinostat (ITF-2357) is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively.
Synonyms: HDAC-IN-2; ACY-241
ACY-241 is a new, selective and orally available inhibitor of HDAC6.
Synonyms: LAQ824; NVP-LAQ824
LAQ824 (NVP-LAQ824) is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma.
Synonyms: TSA
Trichostatin A (TSA) inhibits the HDACs 1, 3, 4, 6 and 10 with IC50 values around 20 nM.
Synonyms: NVP-LBH589; LBH589
LBH589 is a hydroxamic acid and acts as a non-selective HDAC inhibitor with IC5o of HDAC1 to be 0.23 nM.
Synonyms: CRA-024781; PCI-24781
PCI-24781 is a broad-spectrum phenyl hydroxamic acid HDAC inhibitor.
Synonyms: JNJ-26481585
JNJ-26481585 (Quisinostat) is a pan-HDAC inhibitor with marked potency toward HDAC1 (IC(50), 0.16 nmol/L).
Synonyms: Zolinza; MK-0683; SAHA
Vorinostat is an inhibitor of HDACs, inhibiting deacetylation and leading to an accumulation of both hyperacetylated histones and transcription factors.